Indefinite Delivery Contract SPE2DU25D1216

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. This is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation method. The purpose is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) across CONUS and OCONUS locations. The contracted products and services include brand-name, generic, and specialty pharmaceuticals, as well as related medical supplies and equipment, encompassing a wide range of therapeutic areas. Multiple primary suppliers will be awarded separate regional contracts, with a single backup supplier for all regions, to ensure resilience and access to vital medical commodities.

This IDC is a critical vehicle for providing comprehensive pharmaceutical support to the Department of Defense (DoD), United States Coast Guard, Designated Providers, and Other Government Agencies, including the Hospital Ships USNS Mercy and USNS Comfort. The award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor with significant federal contracting experience, demonstrates the company's qualifications to deliver the full spectrum of required medical products and supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, efficient contracting mechanism.